Pandemic strategies to boost trial enrollment should staySeptember 13, 2021Lung CancerCOVID-19 UpdatesOncologyCancer
Old saying about prostate cancer not true when it’s metastaticSeptember 7, 2021Genitourinary CancerProstate CancerOncologyCancer
‘Dawn of a new era’ in the treatment of renal cell carcinomaSeptember 7, 2021Genitourinary CancerOncologyCancer
NCCN recommends third COVID-19 dose for patients with cancerSeptember 7, 2021COVID-19 UpdatesOncologyCancer
Although inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021StrokeCardiologyOncologyGenitourinary CancerCancer
Pandemic-related drops in breast cancer screening hit hardest among medically underservedAugust 30, 2021Breast CancerOncologyWomen's HealthCancer
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate CancerAugust 18, 2021Prostate CancerCancerOncology
Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerCancerOncology
Many pandemic-driven changes to cancer clinical trials should remainJuly 28, 2021COVID-19 UpdatesCancerOncologyHealth Policy
Stop using Neutrogena and Aveeno spray sunscreen, J&J warnsJuly 15, 2021Mixed TopicsMelanomaDermatologyCancerOncology
Cancer mortality continues to drop in females as breast cancer reversal loomsJuly 13, 2021Breast CancerLung CancerMelanomaWomen's HealthOncologyCancer
